Compare Lupin with Panacea Biotech - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

LUPIN vs PANACEA BIOTECH - Comparison Results

LUPIN     Change

Lupin is a leading pharmaceutical company with a strong presence in anti-infective, cardiovascular and asthma. Apart from having a strong domestic presence, the company markets its products in the regulated markets of the US and Europe and semi-regul... More

PANACEA BIOTECH 
   Change

Panacea Biotec is the second largest vaccine producer in India and has been ranked as the third largest biotechnology company in India (as per ABLE Survey 2006). While vaccines account for two-thirds of the company's overall revenues, the balance com... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    LUPIN PANACEA BIOTECH LUPIN/
PANACEA BIOTECH
 
P/E (TTM) x 42.2 13.2 319.3% View Chart
P/BV x 3.9 5.1 75.4% View Chart
Dividend Yield % 0.6 0.0 -  

Financials

 LUPIN   PANACEA BIOTECH
EQUITY SHARE DATA
    LUPIN
Mar-20
PANACEA BIOTECH
Mar-19
LUPIN/
PANACEA BIOTECH
5-Yr Chart
Click to enlarge
High Rs882354 249.5%   
Low Rs505138 365.4%   
Sales per share (Unadj.) Rs339.474.6 455.2%  
Earnings per share (Unadj.) Rs-5.96.7 -89.0%  
Cash flow per share (Unadj.) Rs15.515.5 99.8%  
Dividends per share (Unadj.) Rs6.000-  
Dividend yield (eoy) %0.90-  
Book value per share (Unadj.) Rs276.757.2 483.8%  
Shares outstanding (eoy) m453.0061.25 739.6%   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x2.03.3 62.0%   
Avg P/E ratio x-116.636.8 -316.8%  
P/CF ratio (eoy) x44.815.9 282.5%  
Price / Book Value ratio x2.54.3 58.3%  
Dividend payout %-100.90-   
Avg Mkt Cap Rs m314,20115,061 2,086.1%   
No. of employees `00018.32.3 790.9%   
Total wages/salary Rs m29,8681,471 2,030.8%   
Avg. sales/employee Rs Th8,400.61,973.6 425.6%   
Avg. wages/employee Rs Th1,632.0635.6 256.8%   
Avg. net profit/employee Rs Th-147.2176.8 -83.3%   
INCOME DATA
Net Sales Rs m153,7484,567 3,366.5%  
Other income Rs m4,83845 10,798.2%   
Total revenues Rs m158,5854,612 3,438.7%   
Gross profit Rs m24,8492,030 1,224.3%  
Depreciation Rs m9,702540 1,796.7%   
Interest Rs m3,6301,048 346.3%   
Profit before tax Rs m16,355486 3,363.8%   
Minority Interest Rs m40-   
Prior Period Items Rs m390-   
Extraordinary Inc (Exp) Rs m-7,5210-   
Tax Rs m11,57177 15,007.9%   
Profit after tax Rs m-2,694409 -658.5%  
Gross profit margin %16.244.4 36.4%  
Effective tax rate %70.815.9 446.2%   
Net profit margin %-1.89.0 -19.6%  
BALANCE SHEET DATA
Current assets Rs m154,1322,415 6,383.6%   
Current liabilities Rs m92,2529,077 1,016.3%   
Net working cap to sales %40.2-145.9 -27.6%  
Current ratio x1.70.3 628.1%  
Inventory Days Days8265 126.1%  
Debtors Days Days12971 182.3%  
Net fixed assets Rs m89,0828,333 1,069.0%   
Share capital Rs m90661 1,478.0%   
"Free" reserves Rs m124,4613,443 3,615.2%   
Net worth Rs m125,3673,504 3,577.8%   
Long term debt Rs m17,933461 3,888.3%   
Total assets Rs m249,83913,755 1,816.3%  
Interest coverage x5.51.5 376.1%   
Debt to equity ratio x0.10.1 108.7%  
Sales to assets ratio x0.60.3 185.3%   
Return on assets %0.410.6 3.5%  
Return on equity %-2.111.7 -18.4%  
Return on capital %8.738.7 22.6%  
Exports to sales %020.9 0.0%   
Imports to sales %08.1 0.0%   
Exports (fob) Rs mNA954 0.0%   
Imports (cif) Rs mNA372 0.0%   
Fx inflow Rs m51,4501,203 4,276.7%   
Fx outflow Rs m19,470467 4,172.2%   
Net fx Rs m31,980736 4,342.9%   
CASH FLOW
From Operations Rs m14,6881,049 1,400.5%  
From Investments Rs m11,070-54 -20,691.4%  
From Financial Activity Rs m-8,906-1,011 880.5%  
Net Cashflow Rs m16,853-20 -85,545.7%  

Share Holding

Indian Promoters % 46.6 74.5 62.6%  
Foreign collaborators % 0.2 0.0 -  
Indian inst/Mut Fund % 11.3 0.6 1,883.3%  
FIIs % 31.9 1.3 2,453.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 10.1 23.6 42.8%  
Shareholders   98,259 10,259 957.8%  
Pledged promoter(s) holding % 0.0 35.1 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare LUPIN With:   CADILA HEALTHCARE  TTK HEALTHCARE  NEULAND LABS  DISHMAN PHARMA  J.B.CHEMICALS  

Compare LUPIN With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Trades On a Volatile Note, Dow Futures Up by 68 Points(12:30 pm)

Share markets in India are presently trading on a volatile note. The BSE Sensex is trading up by 11 points, flat, at 47,960 levels.

Related Views on News

LUPIN 2019-20 Annual Report Analysis (Annual Result Update)

Dec 7, 2020 | Updated on Dec 7, 2020

Here's an analysis of the annual report of LUPIN for 2019-20. It includes a full income statement, balance sheet and cash flow analysis of LUPIN. Also includes updates on the valuation of LUPIN.

LUPIN Announces Quarterly Results (2QFY21); Net Profit Up 271.3% (Quarterly Result Update)

Nov 6, 2020 | Updated on Nov 6, 2020

For the quarter ended September 2020, LUPIN has posted a net profit of Rs 2 bn (up 271.3% YoY). Sales on the other hand came in at Rs 38 bn (down 12.0% YoY). Read on for a complete analysis of LUPIN's quarterly results.

LUPIN Announces Quarterly Results (1QFY21); Net Profit Down 64.2% (Quarterly Result Update)

Aug 18, 2020 | Updated on Aug 18, 2020

For the quarter ended June 2020, LUPIN has posted a net profit of Rs 1 bn (down 64.2% YoY). Sales on the other hand came in at Rs 35 bn (down 20.2% YoY). Read on for a complete analysis of LUPIN's quarterly results.

LUPIN Announces Quarterly Results (4QFY20); Net Profit Up 35.5% (Quarterly Result Update)

Jun 1, 2020 | Updated on Jun 1, 2020

For the quarter ended March 2020, LUPIN has posted a net profit of Rs 4 bn (up 35.5% YoY). Sales on the other hand came in at Rs 38 bn (down 12.7% YoY). Read on for a complete analysis of LUPIN's quarterly results.

LUPIN Announces Quarterly Results (2QFY20); Net Profit Down 146.4% (Quarterly Result Update)

Nov 7, 2019 | Updated on Nov 7, 2019

For the quarter ended September 2019, LUPIN has posted a net profit of Rs 1 bn (down 146.4% YoY). Sales on the other hand came in at Rs 44 bn (up 10.3% YoY). Read on for a complete analysis of LUPIN's quarterly results.

More Views on News

Most Popular

India: Recovery Stalled by Vaccine Games?(The Honest Truth)

Apr 13, 2021

Ajit Dayal on how India's vaccine strategy will impact the markets.

A Stock with 700% Return Potential Comes with Additional Payoffs(Profit Hunter)

Apr 15, 2021

Narayana Murthy was one of the first unicorn founders to get the backing of this entity...

11x Bankruptcy to Bluechip Stock: A Rare India Revival Story(Profit Hunter)

Apr 16, 2021

There is no stopping this 11-bagger stock from significant upside.

Why Did the Market Crash on Monday?(Fast Profits Daily)

Apr 13, 2021

In this video, I'll you what I think is the real reason behind yesterday's market crash.

A Warning About Bubbles(Fast Profits Daily)

Apr 16, 2021

Those who don't learn from financial history are doomed to lose their money.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

LUPIN SHARE PRICE


Apr 20, 2021 01:00 PM

TRACK LUPIN

COMPARE LUPIN WITH

MARKET STATS